ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,462, issued on Aug. 19, was assigned to Contineum Therapeutics Inc. (San Diego).
"Muscarinic acetylcholine M1 receptor antagonists" was invented by Yifeng Xiong (San Diego), Jeffrey Roppe (Temecula, Calif.), Austin Chih-Yu Chen (San Diego), Yalda Bravo (San Diego), Thomas Schrader (San Diego) and Jill Melissa Baccei (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders as...